Last reviewed · How we verify

NCT06372301: DobAttrAS

Dobutamine Stress Echocardiography in LF/LG Aortic Stenosis and Wild-type Transthyretin Amyloid Cardiomyopathy

Recruiting now NA Last updated 18 April 2024
What this trial tests

NA trial testing Dobutamine stress echocardiography in Transthyretin Amyloid Cardiomyopathy in 24 participants. Currently enrolling.

Timeline
2 April 2024
Primary endpoint
1 November 2025
1 April 2026

Quick facts

Lead sponsorSteen Hvitfeldt Poulsen
PhaseNA
StatusRecruiting now
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposediagnostic
Enrollment24
Start date2 April 2024
Primary completion1 November 2025
Estimated completion1 April 2026
Sites1 location across Denmark

Drugs / interventions tested

Conditions studied

Sponsor

Steen Hvitfeldt Poulsen — full company profile →

Who can join

65 and older, any sex, with Transthyretin Amyloid Cardiomyopathy or Aortic Stenosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this prospective clinical study is improve the diagnosis of Low-flow low-gradient aortic stenosis (LF/LG AS), in patients with co-existing wild-type transthyretin cardiac amyloidosis (ATTRwt). The main question it aims to answer is whether the classic dobutamine-stress echocardiography can be used to determine AS severity in patients with ATTRwt and LF/LG AS This question will be tried to answer by comparing dobutamine stress echocardiography, with the invasively measured aortic valve area (which is considered as the gold standard). In addition we aim to assess the degree of myocardial fibrosis and amyloid infiltration, assessed by light microscopy and cardiac magnetic resonance (CMRI) and evaluation of myocyte mitochondrial function by high resolution respirometry and their relation to AS severity and hemodynamic response to dobutamine.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dobutamine stress echocardiography

Trials testing the same drug.

Other recruiting trials for Transthyretin Amyloid Cardiomyopathy

Currently open trials in the same condition.

Other Steen Hvitfeldt Poulsen trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06372301.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing